首页> 美国卫生研究院文献>Aging (Albany NY) >PHLPP2 is regulated by competing endogenous RNA network in pathogenesis of colon cancer
【2h】

PHLPP2 is regulated by competing endogenous RNA network in pathogenesis of colon cancer

机译:通过在结肠癌发病机制中竞争内源性RNA网络来调节pHLPP2

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Recently, homologous pleckstrin-homology (PH)-domain leucine-rich-repeat protein phosphatases (PHLPP2) has been reported as a tumor suppressor in colon cancer. This study aimed to unravel the possible involvement of long noncoding RNAs (lncRNAs) and microRNAs (miRNAs) regulating PHLPP2 in colon cancer. Expressions of candidate lncRNAs and miRNAs were verified by the RT-qPCR and Western blot analyses in colon cancer. The roles of candidate genes in colon cancer were investigated in HT-29 cells and in mouse tumor xenograft model . PHLPP2, a target of miR-141 and miR-424, was downregulated in colon cancer. PHLPP2 upregulation and miR-141 and miR-424 downregulation suppressed the colon cancer cell proliferation, migration, invasion, and epithelial-mesenchymal transition, and promote cell apoptosis, which also resulted in suppression of tumor metastasis and formation. Furthermore, LINC00402, LINC00461, and SFTA1P were identified as the targets of miR-141 and miR-424 and acted as competitive endogenous RNAs (ceRNAs) of PHLPP2. The upregulation of LINC00402, LINC00461, and SFTA1P was verified to enhance the suppressive effects of PHLPP2 in the pathogenesis of colon cancer. Conjointly, our results demonstrated the suppressive effects of PHLPP2 in colon cancer and proved that LINC00402, LINC00461, and SFTA1P acted as ceRNAs of PHLPP2 by competitive binding to miR-141 and miR-424.
机译:最近,在结肠癌中报道了同源性Pleckstrin-同源性(pH) - 富含亮氨酸浓度的重复蛋白磷酸酶(PHLPP2)作为肿瘤抑制剂。本研究旨在解开长度非编码RNA(LNCRNA)和MicroRNA(miRNA)调节结肠癌PhlPP2的可能涉及。候选LNCRNA和MIRNA的表达是通过结肠癌的RT-QPCR和Western印迹分析验证。在HT-29细胞和小鼠肿瘤异种移植模型中研究了候选基因在结肠癌中的作用。 phlpp2,miR-141和miR-424的靶标在结肠癌中下调。 PHLPP2上调和miR-141和MIR-424下调抑制了结肠癌细胞增殖,迁移,侵袭和上皮 - 间充质转换,促进细胞凋亡,这也导致抑制肿瘤转移和形成。此外,LINC00402,LINC00461和SFTA1P被鉴定为miR-141和miR-424的靶标,并作为pHLPP2的竞争内源性RNA(Cernas)。验证了LINC00402,LINC00461和SFTA1P的上调,以增强PHLPP2在结肠癌发病机制中的抑制作用。同步,我们的结果证明了PhLPP2在结肠癌中的抑制作用,并证明了LINC00402,LINC00461和SFTA1P通过竞争结合MIR-141和MIR-424作用为PHLPP2的CERNAS。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号